Pharmaceuticals

Spatial Omics Solutions Market Size, Share & Trends Analysis Report By Solution Type (Instruments, Consumables, Services), By Sample Analyzed (DNA, RNA, Protein), By Application, By End-User, By Region, And By Segment Forecasts, 2025-2034

Global Spatial Omics Solutions Market Size is valued at USD 457.7 Million in 2024 and is predicted to reach USD 1233.9 Million by the year 2034 at a 10.5% CAGR during the forecast period for 2025-2034. Spatial omics consists of Proteomics, epigenomics, transcriptomics, Genomics, metabolomics and lipidomic. The field of spatial omics combines molecular analysis with geographical information concerning the location of a cell inside a tissue. As ...

Report ID: 1352  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 175

Polycystic Ovary Syndrome (PCOS) Treatment Market Size, Share & Trends Analysis Report By Drug Class / Therapy Type (Insulin-Sensitizing Agents, Oral Contraceptives, Anti-Androgens, Anti-Obesity Drugs, Others (Combination / Adjunct Therapies), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies / Drug Stores, Online Pharmacies), By Route of Administration (Oral Drugs, Injectable Drugs), By Region and By Segments Forecasts, 2025-2034

Global Polycystic Ovary Syndrome (PCOS) Treatment Market Size is valued at USD 4.5 Bn in 2024 and is predicted to reach USD 8.0 Bn by the year 2034 at a 6.1% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The polycystic ovarian syndrome treatment market experienced growth due to a rise in PCOS prevalence and an increase in the patient population. Research and development in PCOS also assi...

Report ID: 1455  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 175

Flow Cytometry Services Market Size, Share & Trends Analysis Report By Accreditation Type (Government, Third-Party Accreditations), By Service Type (General Flow Cytometric Services, Analysis based Flow Cytometric Services, Other types of Flow Cytometric Services), By Region, And Segment Forecasts, 2025-2034

Global Flow Cytometry Services Market Size is valued at USD 3.2 Billion in 2024 and is predicted to reach USD 7.7 Billion by the year 2034 at a 9.3% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report:   This market growth is being attributed to the increasing prevalence of HIV/AIDS and cancer, as well as new technological advancements in flow cytometry instruments. The growing uses o...

Report ID: 1209  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Blood-Based Biomarker for Sports Medicine Market Current Trends Analysis 2025 to 2034

Global Blood-Based Biomarker for Sports Medicine Market is valued at USD 757.8 Million in 2024 and is predicted to reach USD 1,423.9 Million by the year 2034 at a 7.8% CAGR during the forecast period for 2025 to 2034. Blood-Based Biomarker for Sports Medicine Market Size, Share & Trends Analysis Report By Type (CK, Myoglobin, Lactate, WBC, Urea, CRP, Lipid and Protein Hydroperoxides, IL-6), By Region, And By Segment Forecasts, 2025 to 2034 ...

Report ID: 2940  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Respiratory Inhalers Market Size, Share & Trends Analysis Report By Products (Metered Dosage, Dry Powder Inhaler, Nebulizers, Compressed Air Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers), By Patients, By Technology, ByEnd-Users, By Region, And By Segment Forecasts, 2025-2034

Global Respiratory Inhalers Market Size is valued at USD 33.6 Billion in 2024 and is predicted to reach USD 59.7 Billion by the year 2034 at a 6.0% CAGR during the forecast period for 2025-2034. Respiratory inhalers are devices that are used to inhale medications that are an important part of the treatment for chronic lung diseases. Dry powder inhalers, metered-dose inhalers (MDIs), nebulizers, and soft mist inhalers are just a few of the prod...

Report ID: 1288  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 190

Vaccine Cold Chain Logistics Market Size, Share & Trends Analysis Report By Service (Storage, Packaging, Transportation), By Packaging Method, By Mode of Transportation, By Holding Temperature Range, By Container, By Region, And Segment Forecasts, 2025-2034

Global Vaccine Cold Chain Logistics Market Size is valued at USD 3.5 Billion in 2024 and is predicted to reach USD 5.9 Billion by the year 2034 at a 5.3% CAGR during the forecast period for 2025-2034. Technological advancements have helped in the development of vaccines in recent years. Vaccines are widely used to control infectious diseases as one of the prevention strategies to maintain the sustainable health of the population. The current c...

Report ID: 1127  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Active Pharmaceutical Ingredients Market Size, Share, Trend Report 2026 to 2035

What is Active Pharmaceutical Ingredients Market Size? Global Active Pharmaceutical Ingredients Market Size is valued at USD 190.06 Billion in 2025 and is predicted to reach USD 405.59 Billion by the year 2035 at a 8.0% CAGR during the forecast period for 2026 to 2035.  Active Pharmaceutical Ingredients Market Size, Share & Trends Analysis Report, By Type (Innovative APIs Generic APIs), By Type of Drug (Prescription, Over the...

Report ID: 1768  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Small Molecule Innovator CDMO Market Size, Share & Trends Analysis Report by Product (Small Molecule API, Small Molecule Drug Product), By Stage Type (Preclinical, Phase I, Phase II, Phase III, and Commercial), By Customer Type (Pharmaceutical and Biotechnology), By Therapeutic Area, Region And Segment Forecasts, 2025-2034

Global Small Molecule Innovator CDMO Market Size is valued at USD 51.2 Billion in 2024 and is predicted to reach USD 93.6 Billion by the year 2034 at a 6.3% CAGR during the forecast period for 2025-2034. The small molecule innovator CDMO (Contract Development and Manufacture Organization) market is a subset of the pharmaceutical business that provides contract services for small molecule drug development and manufacture. Small molecule pharmac...

Report ID: 1963  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180

Pharma Contract Commercialization (CCO) Market Size, Share & Trends Analysis Report By services (Value, Evidence and Access, Medical Affairs, Policy, Marketing, Sales and Consulting, Others), business model and end user, Region And Segment Forecasts, 2025-2034

Global Pharma Contract Commercialization (CCO) Market Size is valued at USD 42.6 Billion in 2024 and is predicted to reach USD 69.7 Billion by the year 2034 at a 5.1% CAGR during the forecast period for 2025-2034. A contract commercial organization (CCO) gives pharmaceutical businesses commercial services in order to boost performance, reduce risk, and speed up the transmission of medical innovation to patients. The main drivers of the pharma ...

Report ID: 2068  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 177

Fermentation Enabled Alternative Protein Market Size, Share & Trends Analysis Report By Process (Precision, Biomass, and Traditional Fermentation), By product type (Dairy, Meat, Egg white, Others), Region, And Segment Forecasts, 2025-2034

Fermentation Enabled Alternative Protein Market Size is valued at 472.91 Mn in 2024 and is predicted to reach 1768.38 Mn by the year 2034 at an 14.2% CAGR during the forecast period for 2025-2034.   The alternative protein industry can be divided into three main areas: plant-based alternative proteins, cell-based alternative proteins, and fermentation-based alternative proteins. Fermentation-enabled alternative protein ...

Report ID: 1928  |  

Delivery: Immediate  |  

Published: April 2025   |  

No. of Pages: 180